Medios AG (HAM:ILM1) ROCE %: 5.64% (As of Mar. 2026)

What is Medios AG ROCE %?

Medios AG HAM:ILM1 +1.02% 88 ROCE % is 5.64% as of Mar. 2026. GuruFocus rates HAM:ILM1 with a GF Score™ of 88/100 and a GF Value™ of €17.21 (Significantly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medios AG's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.64%.

Medios AG (HAM:ILM1) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medios AG ROCE % Related Terms

Medios AG ROCE % Historical Data

* Premium members only.

The historical data trend for Medios AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medios AG ROCE % Chart

Medios AG Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

5.15

6.29

6.32

5.13

6.33

Medios AG Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															6.61	6.01	6.60	6.22	5.64

88GF Score

Medios AG HAM:ILM1

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medios AG ROCE % Calculation

Medios AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	47.02	/	( ( (934.357 - 171.067)	+	(903.041 - 181.308) )	/ 2 )
	=	47.02	/	( (763.29	+	721.733)	/ 2 )
	=	47.02	/	742.5115
	=	6.33 %

Medios AG's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	40.864	/	( ( (903.041 - 181.308)	+	(918.226 - 190.085) )	/ 2 )
	=	40.864	/	( ( 721.733	+	728.141 )	/ 2 )
	=	40.864	/	724.937
	=	5.64 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 5.64% mean?

Medios AG (HAM:ILM1) has a ROCE % of 5.64% as of Mar. 2026.

Is Medios AG's ROCE % too high?

Medios AG's current ROCE % is 5.64%. The Medical Distribution industry median ROCE % is 9.22. Medios AG's value of 5.64% is 38.8% below this industry median. Overall, Medios AG has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Medios AG's ROCE % compare to MCK and COR?

Medios AG's ROCE % of 5.64% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. Medios AG's value of 5.64% is 38.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Distribution company?

The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current ROCE % of 5.64% is 38.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current ROCE % is 5.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medios AG stock overvalued right now?

Based on GuruFocus' analysis, Medios AG (HAM:ILM1) is currently considered Significantly Undervalued. The stock's GF Value™ is €17.21, compared to a current price of €11.92 — trading 30.7% below its estimated fair value. The current ROCE % is 5.64% and 38.8% below the Medical Distribution industry median of 9.22. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Medios AG (HAM:ILM1), the current ROCE % is 5.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medios AG (HAM:ILM1) Overvalued in 2026?

Based on GuruFocus' analysis, Medios AG stock appears to be undervalued. The current stock price of €11.92 is trading 30.7% below its estimated GF Value™ of €17.21. GuruFocus considers Medios AG to be Significantly Undervalued.

Key valuation signals for HAM:ILM1:

ROCE %: 5.64%
GF Value™: €17.21 vs. price of €11.92 (30.7% below fair value)
GF Score™: 88/100 with 2 warning signs
Industry Position: 38.8% below the Medical Distribution median

No single metric tells the full story. See the HAM:ILM1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medios AG Business Description

Industry Healthcare Medical Distribution

Comparable Companies XTER:M12 STU:BMP FRA:TLIK MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 TSE:2784 SHSE:600739 NZSE:EBO

Other Exchanges 0QB4:UK ILM1:Germany ILM1:Austria

Address Heidestrasse 9, Berlin, DEU, 10557

Website https://www.medios.ag

Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.

88GF Score

Get the complete analysis for HAM:ILM1

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.92

Price

€17.21

GF Value

View HAM:ILM1 Analysis

See ROCE % data for all stocks →